Article Details

Oppenheimer Reiterates “$3.00” Price Target for Bioline RX (NASDAQ:BLRX)

Retrieved on: 2017-12-14 06:18:45

Tags for this article:

Click the tags to see associated articles and topics

Oppenheimer Reiterates “$3.00” Price Target for Bioline RX (NASDAQ:BLRX). View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC purchased a new position in Bioline RX Ltd (NASDAQ:BLRX) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 131,480 shares of the biotechnology company's stock, valued ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up